Abstract/Poster Submission

Abstract Submission Guidelines 

Submission deadline

Abstracts should be submitted at the latest on August 4th, 2023.


Abstracts must be written and presented in English.


Use a concise descriptive title that indicates the content of the abstract. Commercial trade names for drugs, devices, products and services may NOT be used in the title.


Names and surnames for each author must be provided. Do not include degrees or titles.


Abstracts should not exceed 250 words. Abstract that are not written in understandable English will be rejected and/or returned to the author(s) for revision. The body of the abstract text must be formatted with the following sub-headings as appropriate. Each sub-heading should begin on a new line, and followed by a colon and space (: ). The text for each sub-section should begin immediately after the colon and space.

Drugs, devices, products, and services should be identified by generic name only within the abstract.

Layout structure

The format of the abstract should be: Background, Objective, Methods, Results and Conclusions.


Please note that all presenters should register for the conference.


This presentation/poster shouldn't be a variation of any previous version presented at a conference

The poster should be printed by the presenter in A0 size

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

About Us

The Biomedical / Clinical Engineering Association of Ireland (BEAI) is a company limited by guarantee and not having a share capital. Company Registration no. 484921.

Stay Connected on:


Important Information

Contact Us

For general information, including registration, please contact us at:

  • 8 Priory Office Park, Stillorgan Road,
  • Blackrock, Co Dublin, Ireland,
  • A94 EE95